ID

13642

Descrizione

Ranolazine for the Prevention of Atrial Fibrillation After Electrical Cardioversion; ODM derived from: https://clinicaltrials.gov/show/NCT01349491

collegamento

https://clinicaltrials.gov/show/NCT01349491

Keywords

  1. 22/02/16 22/02/16 -
Caricato su

22 febbraio 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Atrial Fibrillation NCT01349491

Eligibility Atrial Fibrillation NCT01349491

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female with persistent atrial fibrillation, aged 21 or older
Descrizione

atrial fibrillation; age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004238
UMLS CUI [2]
C0001779
duration of atrial fibrillation less than one year
Descrizione

atrial fibrillation

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004238
the patient does not have any contraindications for anticoagulation
Descrizione

Anticoagulation contraindicated

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1531588
the patient is willing to participate in the study for a total of 6 months with 3 outpatient office visits
Descrizione

compliance

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1321605
the patient has provided written informed consent during the screening visit to any test or procedure being performed, or medication being changed, for this study.
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
the patient has no clinically significant abnormal clinical laboratory values, which in the investigator's opinion precludes the patient from safely participating in the study.
Descrizione

laboratory value; patient safety

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0011911
UMLS CUI [2]
C1113679
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
any contraindication for anticoagulation
Descrizione

Anticoagulation contraindicated

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1531588
new york heart association class iv heart failure
Descrizione

new york heart association class iv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1319796
currently taking anti-arrhythmic drugs
Descrizione

anti-arrhythmic drugs

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003195
chronic kidney disease (serum creatinine less than 2.5mg/dl) or severe liver dysfunction
Descrizione

chronic kidney disease; Liver Dysfunction

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1561643
UMLS CUI [2]
C0086565
pregnancy/nursing
Descrizione

pregnant; lactating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2828358
UMLS CUI [2]
C0549206
prolonged qt interval (>500ms)
Descrizione

prolonged qt interval

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0151878
taking other medications known to prolong the qt interval
Descrizione

medication prolonged qt interval

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0151878
taking other medications known to affect the metabolism of ranolazine
Descrizione

ranolazine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0073633

Similar models

Eligibility Atrial Fibrillation NCT01349491

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
atrial fibrillation; age
Item
male or female with persistent atrial fibrillation, aged 21 or older
boolean
C0004238 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
atrial fibrillation
Item
duration of atrial fibrillation less than one year
boolean
C0004238 (UMLS CUI [1])
Anticoagulation contraindicated
Item
the patient does not have any contraindications for anticoagulation
boolean
C1531588 (UMLS CUI [1])
compliance
Item
the patient is willing to participate in the study for a total of 6 months with 3 outpatient office visits
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
the patient has provided written informed consent during the screening visit to any test or procedure being performed, or medication being changed, for this study.
boolean
C0021430 (UMLS CUI [1])
laboratory value; patient safety
Item
the patient has no clinically significant abnormal clinical laboratory values, which in the investigator's opinion precludes the patient from safely participating in the study.
boolean
C0011911 (UMLS CUI [1])
C1113679 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Anticoagulation contraindicated
Item
any contraindication for anticoagulation
boolean
C1531588 (UMLS CUI [1])
new york heart association class iv
Item
new york heart association class iv heart failure
boolean
C1319796 (UMLS CUI [1])
anti-arrhythmic drugs
Item
currently taking anti-arrhythmic drugs
boolean
C0003195 (UMLS CUI [1])
chronic kidney disease; Liver Dysfunction
Item
chronic kidney disease (serum creatinine less than 2.5mg/dl) or severe liver dysfunction
boolean
C1561643 (UMLS CUI [1])
C0086565 (UMLS CUI [2])
pregnant; lactating
Item
pregnancy/nursing
boolean
C2828358 (UMLS CUI [1])
C0549206 (UMLS CUI [2])
prolonged qt interval
Item
prolonged qt interval (>500ms)
boolean
C0151878 (UMLS CUI [1])
medication prolonged qt interval
Item
taking other medications known to prolong the qt interval
boolean
C0013227 (UMLS CUI [1,1])
C0151878 (UMLS CUI [1,2])
ranolazine
Item
taking other medications known to affect the metabolism of ranolazine
boolean
C0073633 (UMLS CUI [1])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial